These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 29900052)
1. TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor Hamada T; Soong TR; Masugi Y; Kosumi K; Nowak JA; da Silva A; Mu XJ; Twombly TS; Koh H; Yang J; Song M; Liu L; Gu M; Shi Y; Nosho K; Morikawa T; Inamura K; Shukla SA; Wu CJ; Garraway LA; Zhang X; Wu K; Meyerhardt JA; Chan AT; Glickman JN; Rodig SJ; Freeman GJ; Fuchs CS; Nishihara R; Giannakis M; Ogino S Oncoimmunology; 2018; 7(7):e1442999. PubMed ID: 29900052 [TBL] [Abstract][Full Text] [Related]
2. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status. Hamada T; Cao Y; Qian ZR; Masugi Y; Nowak JA; Yang J; Song M; Mima K; Kosumi K; Liu L; Shi Y; da Silva A; Gu M; Li W; Keum N; Zhang X; Wu K; Meyerhardt JA; Giovannucci EL; Giannakis M; Rodig SJ; Freeman GJ; Nevo D; Wang M; Chan AT; Fuchs CS; Nishihara R; Ogino S J Clin Oncol; 2017 Jun; 35(16):1836-1844. PubMed ID: 28406723 [TBL] [Abstract][Full Text] [Related]
3. Tumour CD274 (PD-L1) expression and T cells in colorectal cancer. Masugi Y; Nishihara R; Yang J; Mima K; da Silva A; Shi Y; Inamura K; Cao Y; Song M; Nowak JA; Liao X; Nosho K; Chan AT; Giannakis M; Bass AJ; Hodi FS; Freeman GJ; Rodig S; Fuchs CS; Qian ZR; Ogino S Gut; 2017 Aug; 66(8):1463-1473. PubMed ID: 27196573 [TBL] [Abstract][Full Text] [Related]
4. Association of Ugai T; Zhao M; Shimizu T; Akimoto N; Shi S; Takashima Y; Zhong R; Lau MC; Haruki K; Arima K; Fujiyoshi K; Langworthy B; Masugi Y; da Silva A; Nosho K; Baba Y; Song M; Chan AT; Wang M; Meyerhardt JA; Giannakis M; Väyrynen JP; Nowak JA; Ogino S Oncoimmunology; 2021; 10(1):1956173. PubMed ID: 34377593 [TBL] [Abstract][Full Text] [Related]
5. Hamada T; Zhang X; Mima K; Bullman S; Sukawa Y; Nowak JA; Kosumi K; Masugi Y; Twombly TS; Cao Y; Song M; Liu L; da Silva A; Shi Y; Gu M; Li W; Koh H; Nosho K; Inamura K; Keum N; Wu K; Meyerhardt JA; Kostic AD; Huttenhower C; Garrett WS; Meyerson M; Giovannucci EL; Chan AT; Fuchs CS; Nishihara R; Giannakis M; Ogino S Cancer Immunol Res; 2018 Nov; 6(11):1327-1336. PubMed ID: 30228205 [TBL] [Abstract][Full Text] [Related]
6. Inverse relationship between Ugai T; Shimizu T; Kawamura H; Ugai S; Takashima Y; Usui G; Väyrynen JP; Okadome K; Haruki K; Akimoto N; Masugi Y; da Silva A; Mima K; Zhang X; Chan AT; Wang M; Garrett WS; Freeman GJ; Meyerhardt JA; Nowak JA; Song M; Giannakis M; Ogino S Clin Transl Immunology; 2023; 12(8):e1453. PubMed ID: 37538192 [TBL] [Abstract][Full Text] [Related]
7. Combined prognostic value of CD274 (PD-L1)/PDCDI (PD-1) expression and immune cell infiltration in colorectal cancer as per mismatch repair status. Ahtiainen M; Wirta EV; Kuopio T; Seppälä T; Rantala J; Mecklin JP; Böhm J Mod Pathol; 2019 Jun; 32(6):866-883. PubMed ID: 30723299 [TBL] [Abstract][Full Text] [Related]
8. Calcium intake and colon cancer risk subtypes by tumor molecular characteristics. Keum N; Liu L; Hamada T; Qian ZR; Nowak JA; Cao Y; da Silva A; Kosumi K; Song M; Nevo D; Wang M; Chan AT; Meyerhardt JA; Fuchs CS; Wu K; Ogino S; Nishihara R; Zhang X Cancer Causes Control; 2019 Jun; 30(6):637-649. PubMed ID: 30963391 [TBL] [Abstract][Full Text] [Related]
9. Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma. Noh BJ; Kwak JY; Eom DW BMC Cancer; 2020 Jan; 20(1):58. PubMed ID: 31992245 [TBL] [Abstract][Full Text] [Related]
10. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability. Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features. Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972 [TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717 [TBL] [Abstract][Full Text] [Related]
13. Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability. Cho J; Chang YH; Heo YJ; Kim S; Kim NK; Park JO; Kang WK; Lee J; Kim KM ESMO Open; 2018; 3(3):e000326. PubMed ID: 29636988 [TBL] [Abstract][Full Text] [Related]
14. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer. Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779 [TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment classification based on T-cell infiltration and PD-L1 in patients with mismatch repair-proficient and -deficient colorectal cancer. Liu S; Kong P; Wang X; Yang L; Jiang C; He W; Quan Q; Huang J; Xie Q; Xia X; Zhang B; Xia L Oncol Lett; 2019 Feb; 17(2):2335-2343. PubMed ID: 30675299 [TBL] [Abstract][Full Text] [Related]
16. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352 [TBL] [Abstract][Full Text] [Related]
17. Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction. Fujiyoshi K; Chen Y; Haruki K; Ugai T; Kishikawa J; Hamada T; Liu L; Arima K; Borowsky J; Väyrynen JP; Zhao M; Lau MC; Gu S; Shi S; Akimoto N; Twombly TS; Drew DA; Song M; Chan AT; Giovannucci EL; Meyerhardt JA; Fuchs CS; Nishihara R; Lennerz JK; Giannakis M; Nowak JA; Zhang X; Wu K; Ogino S JNCI Cancer Spectr; 2020 Aug; 4(5):pkaa040. PubMed ID: 32923934 [TBL] [Abstract][Full Text] [Related]
18. Deciphering Microenvironment of NSCLC based on CD8+ TIL Density and PD-1/PD-L1 Expression. Lin Z; Gu J; Cui X; Huang L; Li S; Feng J; Liu B; Zhou Y J Cancer; 2019; 10(1):211-222. PubMed ID: 30662542 [No Abstract] [Full Text] [Related]
19. Increased CD8 Tumor Infiltrating Lymphocytes in Colorectal Cancer Microenvironment Supports an Adaptive Immune Resistance Mechanism of PD-L1 Expression. Sudoyo AW; Kurniawan AN; Kusumo GD; Putra TP; Rexana FA; Yunus M; Budiyati AD; Kurniawan D; Utama A; Utomo AR Asian Pac J Cancer Prev; 2019 Nov; 20(11):3421-3427. PubMed ID: 31759368 [TBL] [Abstract][Full Text] [Related]
20. Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma. Yang CY; Lin MW; Chang YL; Wu CT; Yang PC Eur J Cancer; 2016 Apr; 57():91-103. PubMed ID: 26901614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]